# Paul Winner

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paul-winner/

## Facts

| Field | Value |
| --- | --- |
| Citations | 9,200 |
| Field | Migraine and Headache Studies |
| h-index | 40 |
| i10-index | 89 |
| Last Known Institution | Premiere Research Institute |
| OpenAlex ID | https://openalex.org/A5103336919 |
| Works | 158 |

## Researcher papers

- [Donanemab in Early Symptomatic Alzheimer Disease](https://scholariq.org/papers/donanemab-in-early-symptomatic-alzheimer-disease/)
- [Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial](https://scholariq.org/papers/safety-and-efficacy-of-erenumab-for-preventive-treatment-of-chronic-migraine-a/)
- [Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial](https://scholariq.org/papers/efficacy-and-tolerability-of-mk-0974-telcagepant-a-new-oral-antagonist-of/)
- [OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56‐Week PREEMPT Clinical Program](https://scholariq.org/papers/onabotulinumtoxina-for-treatment-of-chronic-migraine-pooled-analyses-of-the-56/)
- [A Randomized, Double-Blind, Placebo-Controlled Study of Sumatriptan Nasal Spray in the Treatment of Acute Migraine in Adolescents](https://scholariq.org/papers/a-randomized-double-blind-placebo-controlled-study-of-sumatriptan-nasal-spray-in/)
- [Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders](https://scholariq.org/papers/atomoxetine-treatment-in-children-and-adolescents-with-adhd-and-comorbid-tic/)
- [Topiramate for Migraine Prevention in Children: A Randomized, Double‐Blind, Placebo‐Controlled Trial](https://scholariq.org/papers/topiramate-for-migraine-prevention-in-children-a-randomized-double-blind-placebo/)
- [Prevalence and Burden of Chronic Migraine in Adolescents: Results of the Chronic Daily Headache in Adolescents Study (C‐dAS)](https://scholariq.org/papers/prevalence-and-burden-of-chronic-migraine-in-adolescents-results-of-the-chronic/)
- [Use of the ICHD‐II Criteria in the Diagnosis of Pediatric Migraine](https://scholariq.org/papers/use-of-the-ichd-ii-criteria-in-the-diagnosis-of-pediatric-migraine/)
- [Rizatriptan 5 mg for the Acute Treatment of Migraine in Adolescents: A Randomized, Double‐Blind, Placebo‐Controlled Study](https://scholariq.org/papers/rizatriptan-5-mg-for-the-acute-treatment-of-migraine-in-adolescents-a-randomized/)
- [Factors Associated with Direct Health Care Costs Among Patients with Migraine](https://scholariq.org/papers/factors-associated-with-direct-health-care-costs-among-patients-with-migraine/)

## Researcher topics

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Neurological Complications and Syndromes](https://scholariq.org/topics/neurological-complications-and-syndromes/)
- [Sympathectomy and Hyperhidrosis Treatments](https://scholariq.org/topics/sympathectomy-and-hyperhidrosis-treatments/)
- [Ophthalmology and Eye Disorders](https://scholariq.org/topics/ophthalmology-and-eye-disorders/)
- [Traumatic Brain Injury Research](https://scholariq.org/topics/traumatic-brain-injury-research/)

## Researcher university

- [Premiere Research Institute](https://scholariq.org/institutions/premiere-research-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.